<!--
title: Ketamine
description: 
published: true
date: 2022-07-27T21:30:55.542Z
tags: 
editor: ckeditor
dateCreated: 2022-07-27T20:38:34.367Z
-->

<h1>Ketamine</h1><div class="mw-parser-output"><p><i>Ketamine</i> is an anesthetic, used to induce a loss of consciousness, relieve pain, and hallucinogenic/dissociative effects.
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Properties"><span class="tocnumber">1</span> <span class="toctext">Properties</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Contraindications"><span class="tocnumber">2</span> <span class="toctext">Contraindications</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Routes_of_Administration"><span class="tocnumber">3</span> <span class="toctext"><span>Routes of Administration</span></span></a>
<ul>
<li class="toclevel-2 tocsection-4"><a href="#Subcutaneous"><span class="tocnumber">3.1</span> <span class="toctext">Subcutaneous</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Nasal"><span class="tocnumber">3.2</span> <span class="toctext">Nasal</span></a>
<ul>
<li class="toclevel-3 tocsection-6"><a href="#Bioavailability"><span class="tocnumber">3.2.1</span> <span class="toctext">Bioavailability</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-7"><a href="#Intramuscular"><span class="tocnumber">3.3</span> <span class="toctext">Intramuscular</span></a>
<ul>
<li class="toclevel-3 tocsection-8"><a href="#Sites"><span class="tocnumber">3.3.1</span> <span class="toctext">Sites</span></a></li>
<li class="toclevel-3 tocsection-9"><a href="#Complications"><span class="tocnumber">3.3.2</span> <span class="toctext">Complications</span></a></li>
<li class="toclevel-3 tocsection-10"><a href="#Pharmacokinetics"><span class="tocnumber">3.3.3</span> <span class="toctext">Pharmacokinetics</span></a></li>
<li class="toclevel-3 tocsection-11"><a href="#Dosage"><span class="tocnumber">3.3.4</span> <span class="toctext">Dosage</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Quantitative_Composition"><span class="tocnumber">4</span> <span class="toctext"><span>Quantitative Composition</span></span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#Solubility"><span class="tocnumber">5</span> <span class="toctext">Solubility</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Melting_Point"><span class="tocnumber">6</span> <span class="toctext">Melting Point</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Tolerance"><span class="tocnumber">7</span> <span class="toctext">Tolerance</span></a>
<ul>
<li class="toclevel-2 tocsection-16"><a href="#Permatolerance"><span class="tocnumber">7.1</span> <span class="toctext">Permatolerance</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Experience_Reports"><span class="tocnumber">7.2</span> <span class="toctext">Experience Reports</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-18"><a href="#Interactions"><span class="tocnumber">8</span> <span class="toctext">Interactions</span></a></li>
<li class="toclevel-1 tocsection-19"><a href="#Sources"><span class="tocnumber">9</span> <span class="toctext">Sources</span></a></li>
</ul>
</div>

<h2><span class="mw-headline" id="Properties">Properties</span></h2>
<table class="wikitable">
<tbody><tr>
<th>Bioavailability
</th>
<td>
<ul><li>Intravenous: 100%</li>
<li>Intramuscular: 93%</li>
<li>Subcutaneous: high</li>
<li>Epidural: 77%</li>
<li>Intranasal: 45â€“50%</li>
<li>Sublingual: 24â€“30%</li>
<li>Rectal: 25â€“30%</li>
<li>By mouth: 16â€“20%</li></ul>
</td></tr>
<tr>
<th>Protein binding
</th>
<td>23 to 47%.
</td></tr>
<tr>
<th>Metabolism
</th>
<td>Liver, intestine (oral):
<ul><li>Major: CYP3A4, CYP2B6</li></ul>
</td></tr>
<tr>
<th>Metabolites
</th>
<td>
<ul><li>Norketamine</li>
<li>Dehydronorketamine</li>
<li>Hydroxynorketamine</li></ul>
</td></tr>
<tr>
<th>Onset of action
</th>
<td>
<ul><li>Intravenous: seconds</li>
<li>Intramuscular: 1â€“5 min</li>
<li>Subcutaneous: 15â€“30 min</li>
<li>Insufflation: 5â€“10 min</li>
<li>By mouth: 15â€“30 min</li></ul>
</td></tr>
<tr>
<th>Elimination half-life
</th>
<td>
<ul><li>Ketamine: 2.5â€“3 hours</li>
<li>Norketamine: 12 hours</li></ul>
</td></tr>
<tr>
<th>Duration of action
</th>
<td>
<ul><li>Intramuscular: 0.5â€“2 hours</li>
<li>Insufflation: 45â€“60 min</li>
<li>By mouth: 1â€“6+ hours</li></ul>
</td></tr>
<tr>
<th>Excretion
</th>
<td>
<ul><li>Urine: 91%</li>
<li>Feces: 3%</li></ul>
</td></tr></tbody></table>
<p><span style="font-size: 18pt;"></span></p><div class="sectionHeader2ndLevel">
<h2><span class="mw-headline" id="Contraindications">Contraindications</span></h2>
</div><div><p>Ketamine is contra-indicated in persons in whom an elevation of <a href="https://wiki.crowdsourcingcures.org/wiki/Blood_Pressure" title="Blood Pressure">blood pressure</a> would constitute a serious hazard.</p><p>Ketamine should not be used in patients with eclampsia or pre-eclampsia, severe coronary or myocardial disease, cerebrovascular accident or cerebral trauma.</p></div>
<h2><span class="mw-headline" id="Routes_of_Administration"><span style="font-size: 18pt;">Routes of Administration</span></span></h2>
<table class="wikitable">
<tbody><tr>
<th colspan="1" rowspan="1">Route of administration
</th>
<th colspan="1" rowspan="1">Starting dose
</th>
<th>For Average Human Weight of 62 <b>kg (137lbs)</b>
</th></tr>
<tr>
<td colspan="1"><a href="https://wiki.crowdsourcingcures.org/index.php?title=Intravenous&amp;action=edit&amp;redlink=1" class="new" title="Intravenous (page does not exist)">Intravenous</a>
</td>
<td colspan="1" rowspan="1">0.25â€“2 mg/kg
</td>
<td>15 mg-124 mg
</td></tr>
<tr>
<td colspan="1"><a href="https://wiki.crowdsourcingcures.org/wiki/Intraosseous" title="Intraosseous">Intraosseous</a>
</td>
<td colspan="1" rowspan="1">0.5âˆ’2 mg/kg
</td>
<td>31 mg-124 mg
</td></tr>
<tr>
<td colspan="1"><a href="https://wiki.crowdsourcingcures.org/index.php?title=Intramuscular&amp;action=edit&amp;redlink=1" class="new" title="Intramuscular (page does not exist)">Intramuscular</a>
</td>
<td colspan="1" rowspan="1">4âˆ’10 mg/kg
</td>
<td>240 mg-620 mg
</td></tr>
<tr>
<td colspan="1">By mouth
</td>
<td colspan="1" rowspan="1">3âˆ’15 mg/kg
</td>
<td>180 mg-900 mg
</td></tr>
<tr>
<td colspan="1">Intranasal
</td>
<td colspan="1" rowspan="1">0.25âˆ’9 mg/kg
</td>
<td>15 mg-360 mg
</td></tr></tbody></table>
<h3><span class="mw-headline" id="Subcutaneous">Subcutaneous</span></h3>
<p>2 mg/kg ketamine administered subcutaneously versus 1 mg/kg iv 15 min before surgery <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933765/">provided better pain control</a> for 24 hours.
</p>
<h3><span class="mw-headline" id="Nasal">Nasal</span></h3>
<h4><span class="mw-headline" id="Bioavailability">Bioavailability</span></h4>
<p>It is reported that the bioavailability of nasally administered ketamine in children was approximately 50%.
</p>
<h3><span class="mw-headline" id="Intramuscular">Intramuscular</span></h3>
<p>The bioavailability of intramuscularly administered ketamine is approximate 93%.</p>
<h4><span class="mw-headline" id="Sites">Sites</span></h4>
<p>The primary sites used for <a href="https://wiki.crowdsourcingcures.org/index.php?title=Intramuscular&amp;action=edit&amp;redlink=1" class="new" title="Intramuscular (page does not exist)">intramuscular</a> (IM) injections are the gluteal (buttocks), deltoid (upper arm), and vastus lateralis (lateral thigh) muscles.</p>
<h4><span class="mw-headline" id="Complications">Complications</span></h4>
<p>Potential complications include infections and nerve damage. The latter usually results from the choice of an incorrect site for injection.</p>
<h4><span class="mw-headline" id="Pharmacokinetics">Pharmacokinetics</span></h4><p>
Rapid absorption in many cases, often in under 30 min. </p><p>Although the time to peak drug concentration is often on the order of 1 or 2 hours. </p><p>The rate of drug absorption and the peak drug levels obtained will often differ between sites used for IM injections. This is related to differences in blood flow among muscle groups. The site was chosen for an IM injection in humans and some animals may be a critical factor in whether or not the drug exhibits an effect (Schwartz <i>et al.,</i> 1974).</p>
<h4><span class="mw-headline" id="Dosage">Dosage</span></h4><p>
Intramuscular administration of ketamine in a dose range from 25 to 200 mg has been reported to produce psychotropic effects in humans.</p><div class="sectionHeaderTop">
<h2><span class="mw-headline" id="Quantitative_Composition"><span style="font-size: 18pt;">Quantitative Composition</span></span></h2>
</div><div class="sectionWrapper"><p>Every 1 ml of solution typically contains Ketamine hydrochloride equivalent to 50 mg ketamine base per ml.</p>
<h2><span class="mw-headline" id="Solubility">Solubility</span></h2>
200mg per mL of H<sub>2</sub>O<p class="mw-empty-elt"></p>
<h2><span class="mw-headline" id="Melting_Point">Melting Point</span></h2>
<p>92.5ºC
</p>
<h2><span class="mw-headline" id="Tolerance">Tolerance</span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:302px;"><a href="https://wiki.crowdsourcingcures.org/wiki/File:Ketamine_Tolerance.png" class="image"><img alt="" src="/wiki/images/thumb/f/f0/Ketamine_Tolerance.png/300px-Ketamine_Tolerance.png" decoding="async" width="300" height="305" class="thumbimage" srcset="/wiki/images/f/f0/Ketamine_Tolerance.png 1.5x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="https://wiki.crowdsourcingcures.org/wiki/File:Ketamine_Tolerance.png" class="internal" title="Enlarge"></a></div>Ketamine tolerance has been proven to exist in rats and monkeys.&#160; Tolerance evolves rapidly in both species (figure below).&#160; Among rats, cross-tolerance exists between ketamine and fentanyl (but not morphine).&#160; This raises the possibility that cross-tolerance in humans could exist between ketamine and some synthetic opioids. <a rel="nofollow" class="external free" href="https://emcrit.org/pulmcrit/ketamine-tolerance/">https://emcrit.org/pulmcrit/ketamine-tolerance/</a></div></div></div>Tolerance to the main effects of ketamine develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects.
<p>After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption).
</p><p>Ketamine presents cross-tolerance with all dissociatives, meaning that after the consumption of ketamine all dissociatives will have a reduced effect.
</p>
<h3><span class="mw-headline" id="Permatolerance">Permatolerance</span></h3>
<p>Dissociatives are reported to be unique from other substances because they produce a long-term or permanent form of tolerance ("permatolerance") that accrues slowly and independently from normal tolerance. Many long-term or heavy ketamine users report that they need to take substantially more to achieve dissociation or k-hole compared to their first use, even after taking extended breaks. It is unknown why or how this occurs, although it has been suggested to be a potential indicator of some form of neurotoxicity.
</p>
<h3><span class="mw-headline" id="Experience_Reports">Experience Reports</span></h3>
<p><a rel="nofollow" class="external free" href="https://www.reddit.com/r/ketamine/comments/9awyzx/how_long_until_ketamine_tolerance_should_be_back/">https://www.reddit.com/r/ketamine/comments/9awyzx/how_long_until_ketamine_tolerance_should_be_back/</a>
</p>
<h2><span class="mw-headline" id="Interactions">Interactions</span></h2>
<ul><li><b><a href="https://wiki.crowdsourcingcures.org/index.php?title=Amphetamines&amp;action=edit&amp;redlink=1" class="new" title="Amphetamines (page does not exist)">Amphetamines</a></b> - No unexpected interactions, though likely to increase <a href="https://wiki.crowdsourcingcures.org/wiki/Blood_Pressure" title="Blood Pressure">blood pressure</a> but not an issue with sensible doses. Moving around on high doses of this combination may be ill-advised due to risk of physical injury.</li>
<li><b><a href="https://wiki.crowdsourcingcures.org/index.php?title=Cocaine&amp;action=edit&amp;redlink=1" class="new" title="Cocaine (page does not exist)">Cocaine</a></b> - No unexpected interactions, though likely to increase <a href="https://wiki.crowdsourcingcures.org/wiki/Blood_Pressure" title="Blood Pressure">blood pressure</a> but not an issue with sensible doses. Moving around on high doses of this combination may be ill-advised due to risk of physical injury.</li>
<li><b><a href="https://wiki.crowdsourcingcures.org/index.php?title=Benzodiazepines&amp;action=edit&amp;redlink=1" class="new" title="Benzodiazepines (page does not exist)">Benzodiazepines</a></b> - Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. While unconscious, vomit aspiration is a risk if not placed in the recovery position.</li>
<li><b><a href="https://wiki.crowdsourcingcures.org/wiki/MAOIs" class="mw-redirect" title="MAOIs">MAOIs</a></b> - <a href="https://wiki.crowdsourcingcures.org/wiki/MAO-B" title="MAO-B">MAO-B</a> inhibitors appear to increase the potency of ketamine. <a href="https://wiki.crowdsourcingcures.org/wiki/MAO-A" title="MAO-A">MAO-A</a> inhibitors have some negative reports associated with the combination but there isn't much information available</li>
<li><b><a href="https://wiki.crowdsourcingcures.org/index.php?title=Alcohol&amp;action=edit&amp;redlink=1" class="new" title="Alcohol (page does not exist)">Alcohol</a></b> - Both substances cause ataxia and bring a very high risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.</li>
<li><b><a href="https://wiki.crowdsourcingcures.org/index.php?title=GHB&amp;action=edit&amp;redlink=1" class="new" title="GHB (page does not exist)">GHB</a></b> - Both substances cause ataxia and bring a risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.</li>
<li><b><a href="https://wiki.crowdsourcingcures.org/index.php?title=GBL&amp;action=edit&amp;redlink=1" class="new" title="GBL (page does not exist)">GBL</a></b> - Both substances cause ataxia and bring a risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.</li>
<li><b><a href="https://wiki.crowdsourcingcures.org/index.php?title=Opioids&amp;action=edit&amp;redlink=1" class="new" title="Opioids (page does not exist)">Opioids</a></b> - Both substances bring a risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.</li>
<li><b>Grapefruit</b> - Grapefruit juice significantly increases oral absorption of ketamine. This may result in the user having double the concentration of ketamine in their system compared to normal. The ketamine may also have a longer duration of effect. This is likely to apply to oral, sublingual, and intranasal administration.</li></ul>
<h2><span class="mw-headline" id="Sources">Sources</span></h2>
</div>
<ol><li><a rel="nofollow" class="external free" href="https://pubchem.ncbi.nlm.nih.gov/compound/Ketamine#section=Physical-Description">https://pubchem.ncbi.nlm.nih.gov/compound/Ketamine#section=Physical-Description</a></li>
<li><a rel="nofollow" class="external free" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933765/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933765/</a></li>
<li><a rel="nofollow" class="external free" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933765/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933765/</a></li>
<li><a rel="nofollow" class="external free" href="https://psychonautwiki.org/wiki/Ketamine">https://psychonautwiki.org/wiki/Ketamine</a></li></ol>




</div>
